Watch this recent interview on Ticker Insight with Dr Steven Gourlay providing an update on Actinogen and our successful trial. Chronically elevated cortisol is associated with cognitive decline in Alzheimer's Disease, and Xanamem has shown the ability to improve working memory and attention in healthy, older volunteers.